Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
87.81
+0.71 (0.82%)
Mar 9, 2026, 4:00 PM EDT - Market closed

Company Description

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives.

It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems.

In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution.

Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents.

Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Globus Medical, Inc.
Globus Medical logo
Country United States
Founded 2003
IPO Date Aug 3, 2012
Industry Medical Devices
Sector Healthcare
Employees 6,000
CEO Keith Pfeil

Contact Details

Address:
2560 General Armistead Avenue
Audubon, Pennsylvania 19403-5214
United States
Phone 610 930 1800
Website globusmedical.com

Stock Details

Ticker Symbol GMED
Exchange NYSE
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001237831
CUSIP Number 379577208
ISIN Number US3795772082
Employer ID 04-3744954
SIC Code 3841

Key Executives

Name Position
Keith W. Pfeil Chief Executive Officer, President and Director
David C. Paul Co-Founder and Chairman
Kelly G. Huller Esq. Executive Vice President, General Counsel and Corporate Secretary
Kyle Kline Senior Vice President and Chief Financial Officer
Brian J. Kearns Senior Vice President of Business Development and Investor Relations

Latest SEC Filings

Date Type Title
Feb 25, 2026 144 Filing
Feb 24, 2026 10-K Annual Report
Feb 24, 2026 8-K Current Report
Feb 12, 2026 144 Filing
Jan 8, 2026 144 Filing
Jan 8, 2026 144 Filing
Jan 7, 2026 8-K Current Report
Dec 12, 2025 144 Filing
Dec 1, 2025 144 Filing
Nov 25, 2025 144 Filing